PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance Summary Report: January 1st to March 31st 2023 (Q3)

[featured_image]
  • Version
  • Download 385
  • File Size 1.36 MB
  • File Count 1
  • Create Date August 29, 2023
  • Last Updated September 1, 2023

Pharmacovigilance Summary Report: January 1st to March 31st 2023 (Q3)

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade of drugs and poisons. Practice of Pharmacy and the manufacture and trade of drugs and poisons. PPB has 4 directorates of which the Directorate of Product Safety (PDS) is responsible for Pharmacovigilance, Post-Market Surveillance, Clinical Trials & Medicines Information activities. PDS shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report. Since the introduction of PV in Kenya, a total of 16,675 individual case safety reports has been submitted to the global data reports 35,690,919 (0.05%).

Attached Files

FileAction
PV QUARTERLY SUMMARY_Q3_2022_2023.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published. Required fields are marked *